Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,818,800
-$4,609,019 QoQ
Shares Held
17,210
-54.2% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#248
of 1,040 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CAPITAL FUND MANAGEMENT S.A. holds $150,158,879 across 8 Diagnostics & Research names. LH ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
398,917 | $75,985,710 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
64,723 | $32,449,523 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
33,791 | $17,788,934 | |
| 4 | A |
Agilent Technologies, Inc.
|
54,143 | $7,191,814 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
13,003 | $6,886,258 | |
| 6 | NTRA |
Natera, Inc.
|
18,559 | $5,037,840 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
17,210 | $4,818,800 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
|
21,266 | $0 |
All Filings in LH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,818,800 | 17,210 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $9,427,819 | 37,579 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,207,842 | 18,142 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||